Literature DB >> 7862533

High affinity binding sites for the Wilms' tumour suppressor protein WT1.

T B Hamilton1, K C Barilla, P J Romaniuk.   

Abstract

The Wilms' tumour suppressor protein (WT1) is a putative transcriptional regulatory protein with four zinc fingers, the last three of which have extensive sequence homology to the early growth response-1 (EGR-1) protein. Although a peptide encoding the zinc finger domain of WT1[-KTS] can bind to a consensus 9 bp EGR-1 binding site, current knowledge about the mechanisms of zinc finger-DNA interactions would predict a more extended recognition site for WT1. Using a WT1[-KTS] zinc finger peptide (WT1-ZFP) and the template oligonucleotide GCG-TGG-GCG-NNNNN in a binding site selection assay, we have determined that the highest affinity binding sites for WT1[-KTS] consist of a 12 bp sequence GCG-TGG-GCG-(T/G)(G/A/T)(T/G). The binding of WT1-ZFP to a number of the selected sequences was measured by a quantitative nitrocellulose filter binding assay, and the results demonstrated that these sequences have a 4-fold higher affinity for the protein than the nonselected sequence GCG-TGG-GCG-CCC. The full length WT1 protein regulates transcription of reporter genes linked to these high affinity sequences. A peptide lacking the first zinc finger of WT1[-KTS], but containing the three zinc fingers homologous to EGR-1 failed to select any specific sequences downstream of the GCG-TGG-GCG consensus sequence in the binding site selection assay. DNA sequences in the fetal promoter of the insulin-like growth factor II gene that confer WT1 responsiveness in a transient transfection assay bind to the WT1-ZFP with affinities that vary according to the number of consensus bases each sequence possesses in the finger 1 subsite.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7862533      PMCID: PMC306666          DOI: 10.1093/nar/23.2.277

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  42 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eucaryotic cells.

Authors:  M J Sleigh
Journal:  Anal Biochem       Date:  1986-07       Impact factor: 3.365

3.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

4.  Molecular analysis of chromosome 11 deletions in aniridia-Wilms tumor syndrome.

Authors:  V van Heyningen; P A Boyd; A Seawright; J M Fletcher; J A Fantes; K E Buckton; G Spowart; D J Porteous; R E Hill; M S Newton
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

5.  The beta-subunit of follicle-stimulating hormone is deleted in patients with aniridia and Wilms' tumour, allowing a further definition of the WAGR locus.

Authors:  T Glaser; W H Lewis; G A Bruns; P C Watkins; C E Rogler; T B Shows; V E Powers; H F Willard; J M Goguen; K O Simola
Journal:  Nature       Date:  1986 Jun 26-Jul 2       Impact factor: 49.962

6.  The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains.

Authors:  Z Y Wang; Q Q Qiu; T F Deuel
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

7.  Somatic deletion and duplication of genes on chromosome 11 in Wilms' tumours.

Authors:  E R Fearon; B Vogelstein; A P Feinberg
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

8.  Loss of alleles at loci on human chromosome 11 during genesis of Wilms' tumour.

Authors:  A Koufos; M F Hansen; B C Lampkin; M L Workman; N G Copeland; N A Jenkins; W K Cavenee
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

9.  Loss of a Harvey ras allele in sporadic Wilms' tumour.

Authors:  A E Reeve; P J Housiaux; R J Gardner; W E Chewings; R M Grindley; L J Millow
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

10.  Development of homozygosity for chromosome 11p markers in Wilms' tumour.

Authors:  S H Orkin; D S Goldman; S E Sallan
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

View more
  14 in total

1.  Broad and unexpected phenotypic expression in Greek children with steroid-resistant nephrotic syndrome due to mutations in the Wilms' tumor 1 (WT1) gene.

Authors:  Spyridon Megremis; Andromachi Mitsioni; Irene Fylaktou; Sofia Kitsiou Tzeli; Filadelfia Komianou; Constantinos J Stefanidis; Emmanuel Kanavakis; Joanne Traeger-Synodinos
Journal:  Eur J Pediatr       Date:  2011-04-16       Impact factor: 3.183

2.  Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation.

Authors:  Maike Busch; Heinrich Schwindt; Artur Brandt; Manfred Beier; Nicole Görldt; Paul Romaniuk; Eneda Toska; Stefan Roberts; Hans-Dieter Royer; Brigitte Royer-Pokora
Journal:  Hum Mol Genet       Date:  2014-03-11       Impact factor: 6.150

3.  Genomic characterization of Wilms' tumor suppressor 1 targets in nephron progenitor cells during kidney development.

Authors:  Sunny Hartwig; Jacqueline Ho; Priyanka Pandey; Kenzie Macisaac; Mary Taglienti; Michael Xiang; Gil Alterovitz; Marco Ramoni; Ernest Fraenkel; Jordan A Kreidberg
Journal:  Development       Date:  2010-04       Impact factor: 6.868

4.  Interdependent transcription control elements regulate the expression of the SPRR2A gene during keratinocyte terminal differentiation.

Authors:  D F Fischer; S Gibbs; P van De Putte; C Backendorf
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

5.  RNA Binding by the KTS Splice Variants of Wilms' Tumor Suppressor Protein WT1.

Authors:  Tadateru Nishikawa; Jonathan M Wojciak; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2020-09-29       Impact factor: 3.162

6.  Amine oxidase copper-containing 1 (AOC1) is a downstream target gene of the Wilms tumor protein, WT1, during kidney development.

Authors:  Karin M Kirschner; Julian F W Braun; Charlotte L Jacobi; Lucas J Rudigier; Anja Bondke Persson; Holger Scholz
Journal:  J Biol Chem       Date:  2014-07-17       Impact factor: 5.157

7.  Embryonic neural inducing factor churchill is not a DNA-binding zinc finger protein: solution structure reveals a solvent-exposed beta-sheet and zinc binuclear cluster.

Authors:  Brian M Lee; Bethany A Buck-Koehntop; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  J Mol Biol       Date:  2007-06-15       Impact factor: 5.469

8.  Transcriptional regulation by the Wilms tumor protein, Wt1, suggests a role of the metalloproteinase Adamts16 in murine genitourinary development.

Authors:  Charlotte L J Jacobi; Lucas J Rudigier; Holger Scholz; Karin M Kirschner
Journal:  J Biol Chem       Date:  2013-05-09       Impact factor: 5.157

9.  WT1 expression in the human fetus during development.

Authors:  R Ambu; L Vinci; C Gerosa; D Fanni; E Obinu; A Faa; V Fanos
Journal:  Eur J Histochem       Date:  2015-06-29       Impact factor: 3.188

10.  A new role for wilms tumor protein 1: differential activities of + KTS and -KTS variants to regulate LHβ transcription.

Authors:  Debalina Bagchi; Josefa Andrade; Margaret A Shupnik
Journal:  PLoS One       Date:  2015-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.